Cargando…
Fetuin-A is also an adipokine
Fetuin-A (FetA), which impairs insulin action is considered classically as a hepatokine. In patients with Metabolic Syndrome without the confounding of diabetes or cardiovascular diseases, we showed significant increases in both circulating and subcutaneous adipose tissue secreted Fet-A. Furthermore...
Autores principales: | Jialal, Ishwarlal, Pahwa, Roma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437840/ https://www.ncbi.nlm.nih.gov/pubmed/30917813 http://dx.doi.org/10.1186/s12944-019-1021-8 |
Ejemplares similares
-
Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice
por: Pahwa, Roma, et al.
Publicado: (2017) -
SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome
por: Ramakrishnan, Neeraj, et al.
Publicado: (2020) -
Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019) -
AHA/ACC/Multisociety Cholesterol Guidelines:
highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019) -
Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2012)